As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: July 3, 2012
by Huffington Post:
Scientists at the University of Texas Health Science Center San Antonio are investigating a potential new drug that could improve learning and memory during aging — thanks to Easter Island?
The drug, called rapamycin, comes from isolated bacterial products in the soil of the Polynesian island, known as the home to the famous moai statues. When given to mice, rapamycin seems to boost cognitive skills in young and old mice.
“We made the young ones learn, and remember what they learned, better than what is normal,” study researcher Veronica Galvan, Ph.D., assistant professor of physiology at the Barshop Institute for Longevity and Aging Studies at the UT Health Science Center, said in a statement. “Among the older mice, the ones fed with a diet including rapamycin actually showed an improvement, negating the normal decline that you see in these functions with age.”
The mice in the Neuroscience study also had fewer symptoms of depression and anxiety when given the rapamycin, researchers found.
Rapamycin — which is named for the Polynesian name for Easter Island, Rapa Nui — is already used for antifungal purposes among transplant patients.
In 2009, the Wall Street Journal reported that rapamycin was shown in Naturestudy to help mice live longer.
A new comprehensive study from Florida State University (FSU) finds no evidence to support the idea that personality changes begin before the clinical onset of mild cognitive impairment (MCI) or dementia. MCI is an intermediate...
On the evening of Monday November 27th, join us for conversation and cocktails with award-winning journalist, editor and author Tina Brown, and Indigo’s CEO Heather Reisman. Hear from Tina Brown about her eight-year tenure at Vanity...
The presence of TAR DNA-binding protein 43 (TDP-43) in the hippocampus on postmortem examination is associated with increased rates of hippocampal atrophy in patients with Alzheimer’s disease (AD), new research suggests. This association was greatest...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.